Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01C
- Chemical subgroupL01CB
- Chemical substanceL01CB01Etoposide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 14 registrations
- EvoposdoFarmarin Industria e Comercio Ltda
- CredusBiosintética Farmacêutica Ltda
- EtomeraseInstituto Biochimico Indústria Farmacêutica Ltda
- EtopemOpem Representação Importadora Exportadora e Distribuidora Ltda
Canada
Health Canada · 13 registrations
At a glance
- ATC code
- L01CB01
- Registers
- 9
- Historical lists
- 2
- Registrations
- 76
- With their own page
- 38
- Companies
- 55
All medicines with Etoposide
Human medicines from every register that match Etoposide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
89 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Etoposide | United States | 20MG/ML | injectable | Marketed | Hospira |
| Etoposide | United States | 50MG | capsule | Marketed | Mylan |
| Etoposide Injection | Canada | 20 MG / ML | Solution | Marketed | Teva Canada Limited |
| Etoposide Injection | Canada | 20 MG / ML | Solution | Marketed | Hikma Canada Limited |
| Etoposide Injection | Canada | 20 MG / ML | Liquid | Not marketed | Fresenius Kabi Canada LTD |
| Etoposide Injection, USP | Canada | 20 MG / ML | Solution | Not marketed | Strides Pharma Canada INC |
| ETOPOSIDE-TEVA INJECTION 20 mg/ml | Singapore | 20 mg/ml | injection | Authorised | Teva Pharmaceutical Investments Singapore Pte. LTD. |
| Etoposide Hikma 20 mg/ml concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Hikma Farmaceutica (Portugal), S.A. | |
| Etoposide Accord 20 mg/ml, concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Accord Healthcare B.V. | |
| Etoposide Fresenius Kabi 20 mg/ml, concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Fresenius Kabi Nederland B.V. | |
| Etoposide Sandoz 20 mg/ml koncentrat za otopinu za infuziju | Croatia | koncentrat za otopinu za infuziju | Marketed | Sandoz d.o.o. | |
| Etopophos Preservative Free | United States | 100MG BASE/VIAL, 1GM BASE/VIAL, 500MG BASE/VIAL | injectable | Marketed | Bristol Myers Squibb |
| Vepesid | United States | 100MG, 50MG | capsule | Marketed | Onesource Specialty |
| Avopef | United States | 100MG/5ML | solution | Marketed | Avyxa Holdings |
| Toposar | United States | 20MG/ML | injectable | Not marketed | Teva Parenteral |
| Vepesid | United States | 20MG/ML | injectable | Not marketed | Corden Pharma |
| Etoposid Ebewe® | Serbia | 100mg/5mL | koncentrat za rastvor za infuziju | Authorised | PredstavniŠTvo Sandoz Pharmaceuticals D.D. Beograd |
| ETOPOSIDO TEVA 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | Spain | 20 mg | concentrado para solución para perfusión | Marketed | Teva Gmbh |
| Etoposido Hikma 20 MG/ML Concentrado Para Solucion Para Perfusion Efg | Spain | 20 mg/ml | concentrado para solución para perfusión | Marketed | Hikma Farmaceutica (Portugal) S.A. |
| Etopósido Sandoz 20 MG/ML Concentrado Para Solución Para Perfusión Efg | Spain | 20 mg | concentrado para solución para perfusión | Marketed | Sandoz Farmaceutica S.A. |
| Etoposido Accord 20 MG/ML Concentrado Para Solucion Para Perfusion Efg | Spain | 20,0 mg/ml | concentrado para solución para perfusión | Marketed | Accord Healthcare S.L.U. |
| Etopophos | New Zealand | Inj 100 mg vial | Funded | ||
| Etopophos | New Zealand | Inj 100 mg (of etoposide base) | Funded | ||
| Evoposdo | Brazil | Authorised | Farmarin Industria e Comercio Ltda | ||
| VEPESID 50 mg CAPSULAS BLANDAS | Spain | 50 mg | cápsula blanda | Marketed | Cheplapharm Arzneimittel Gmbh |